Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidanacogene elaparvovec Phase 3 Trial in Male Patients (Japan)
jRCT1080225132Phase 3Completed
- Start
- Mar 2020
- Modality
- Gene Therapies
01
Overview
Phase 3 trial of fidanacogene elaparvovec in hemophilia B (HB). Started Mar 2020; status: completed.
02
Drugs
fidanacogene elaparvovec
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on jRCT1080225132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225132.